93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details

臨床試験数 : 282 / 薬物数 : 245 - (DrugBank : 56) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 113

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02376335 (ClinicalTrials.gov)	October 2012	24/2/2015	B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis	B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis	Fatigue;Primary Biliary Cirrhosis	Biological: Rituximab;Other: Placebo	Newcastle-upon-Tyne Hospitals NHS Trust	National Institute for Health Research, United Kingdom;Department of Health, United Kingdom;Newcastl ...	Completed	18 Years	N/A	All	71	Phase 2	United Kingdom
2	EUCTR2012-000145-12-GB (EUCTR)	15/08/2012	04/07/2012	Pilot study of Rituximab for the treatment of fatigue in PBC	Rituximab for the Treatment of Fatigue in Primary Biliary Cirrhosis (PBC) - RITPBC Study	Severe fatigue in Primary Biliary Cirrhosis MedDRA version: 18.0;Level: PT;Classification code 10004 ...	Trade Name: MabThera ® Product Name: MabThera ® INN or Proposed INN: Rituximab Other descriptive name: N/ ...	The Newcastle upon Tyne Hospitals NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	58	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom
3	NCT00364819 (ClinicalTrials.gov)	January 2007	15/8/2006	Initial Study of Rituximab to Treat Primary Biliary Cirrhosis	Effects of Rituximab (Rituxan) on B Cell and AMA Response in Patients With Primary Biliary Cirrhosis	Primary Biliary Cirrhosis	Drug: rituximab	University of California, Davis	Genentech, Inc.	Completed	18 Years	65 Years	Female	6	Phase 1/Phase 2	United States

First Previous1Next Last